Literature DB >> 19870670

THE COMPOSITION OF SPECIFIC PRECIPITATES IN THE REGION OF ANTIGEN EXCESS.

S Malkiel1, W C Boyd.   

Abstract

Data are given, for seven different antisera, for the composition of the specific precipitate as a function of the relative proportions of antiserum and antigen used. In the region of antigen excess, a linear relation is found between the ratio of antibody to antigen in the precipitate and the amount of antiserum used. The significance of these results, particularly in their bearing on theories of the precipitin reaction, is discussed.

Year:  1937        PMID: 19870670      PMCID: PMC2133613          DOI: 10.1084/jem.66.3.383

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  SPECIAL ARTICLES.

Authors:  M Heidelberger; F E Kendall
Journal:  Science       Date:  1930-09-05       Impact factor: 47.728

2.  A QUANTITATIVE THEORY OF THE PRECIPITIN REACTION : III. THE REACTION BETWEEN CRYSTALLINE EGG ALBUMIN AND ITS HOMOLOGOUS ANTIBODY.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1935-10-31       Impact factor: 14.307

3.  A QUANTITATIVE THEORY OF THE PRECIPITIN REACTION : II. A STUDY OF AN AZOPROTEIN-ANTIBODY SYSTEM.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1935-09-30       Impact factor: 14.307

  3 in total
  3 in total

1.  THE ESSENTIAL DIFFERENCE BETWEEN THE TWO OPTIMUM PROPORTIONS FLOCCULATION RATIOS.

Authors:  W C Boyd; M A Purnell
Journal:  J Exp Med       Date:  1944-10-01       Impact factor: 14.307

2.  THE INFLUENCE OF THE MOLECULAR WEIGHT OF ANTIGEN ON THE PROPORTION OF ANTIBODY TO ANTIGEN IN PRECIPITATES : II. A STATISTICAL EXAMINATION OF AVAILABLE DATA, INCLUDING SOME PREVIOUSLY UNPUBLISHED.

Authors:  W C Boyd; S B Hooker
Journal:  J Gen Physiol       Date:  1939-01-20       Impact factor: 4.086

3.  INFLUENCE OF CHARACTER OF ANTIBODY UPON VELOCITY OF FLOCCULATION.

Authors:  W C Boyd
Journal:  J Exp Med       Date:  1941-09-30       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.